AKTX: Vat-Ho Vatnak reports a stock award
By AlphaYouPublished Form 4
Vat-Ho Vatnak
Reporting filer
Vat-Ho Vatnak reports a stock award, not an open-market purchase or sale, in Akari Therapeutics Plc. Form 4 filed Oct 14, 2026 lists 1 entry.
- Disclosed
- Oct 14, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) (derivative) | Vat-Ho Vatnak | 2026-10-12 | A | Grant or award | 87000 | 0 | 87,000 | 2 days | Filed terms
|
Stock Option (Right to Buy) (derivative)
- Owner
- Vat-Ho Vatnak
- Date
- 2026-10-12
- Code
- A
- Action
- Grant or award
- Quantity
- 87000
- Price
- 0
- Following holdings
- 87,000
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 8.94
- transaction Date: 2026-10-12
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 87000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-10-05
- underlying Security Title: American Depositary Shares representing Ordinary Shares
- underlying Security Shares: 87000
- shares Owned Following Transaction: 87000
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Vat-Ho Vatnak: Chief Business Officer.
- F1: On October 5, 2026 (the "Grant Date"), the reporting person was granted an option to purchase 87,000 ADSs. This option grant is subject to forfeiture and cancellation if shareholder approval of a proposed amendment to the Issuer's equity incentive plan to increase the number of shares reserved for issuance under the plan is not obtained. The option will vest with respect to 25% on the 12-month anniversary of the Grant Date, with the remainder vesting in equal monthly installments over the next 36 months until fully vested on the 4-year anniversary of the Grant Date, subject to the grantee's continued service with the Company.
Original sources
Prepared automatically from public filing data. Report a correction.